Rubius Therapeutics Inc (NASDAQ:RUBY)
| 10.00 Delayed Data As of 3:59pm ET |  +0.52 / +5.49%Today’s Change | 3.35 Today|||52-Week Range 13.70 | +31.75% Year-to-Date |
Latest RUBY News | Press Releases
No recent news for Rubius Therapeutics Inc.
Today’s Trading
| Previous close | 9.48 |
| Today’s open | 9.55 |
| Day’s range | 9.34 - 10.00 |
| Volume | 16,002 |
| Average volume (3 months) | 845,067 |
| Market cap | $767.2M |
Data as of 3:59pm ET, 01/25/2021
Growth & Valuation
| Earnings growth (last year) | +8.51% |
| Earnings growth (this year) | -1.25% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZIOPZIOPHARM Oncology In... | +0.02 | +0.41% |
| VXRTVaxart Inc | +2.92 | +40.90% |
| SYRSSyros Pharmaceutical... | +0.04 | +0.33% |
| ---- |
Data as of 6:22pm ET, 01/25/2021
Financials
| Next reporting date | April 1, 2021 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$163.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
